Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Drop in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Drop in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 262,000 shares, a decrease of 44.3% from the August 15th total of 470,600 shares. Based on an average daily volume of 953,800 shares, the short-interest ratio is presently 0.3 days.
費森尤斯醫療保健股份公司(紐約證券交易所代碼:fms-GET評級)是8月份空頭股數價格大幅下降的接受者。截至8月31日,空頭股數共有26.2萬股,比8月15日的47.06萬股減少了44.3%。以日均成交量953,800股計算,目前短息比率為0.3天。
Fresenius Medical Care AG & Co. KGaA Stock Down 0.7 %
費森尤斯醫療保健股份公司KGaA股價下跌0.7%
NYSE:FMS traded down $0.12 on Friday, hitting $16.67. 1,785,818 shares of the company's stock were exchanged, compared to its average volume of 1,010,924. The firm has a 50-day moving average price of $19.14 and a 200-day moving average price of $26.32. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.18 and a quick ratio of 0.85. Fresenius Medical Care AG & Co. KGaA has a 52 week low of $16.06 and a 52 week high of $36.84. The company has a market cap of $9.77 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 0.84 and a beta of 1.03.
紐約證券交易所:FMS週五下跌0.12美元,觸及16.67美元。該公司股票成交量為1,785,818股,而其平均成交量為1,010,924股。該公司的50日移動均線價格為19.14美元,200日移動均線價格為26.32美元。該公司的債務權益比為0.47,流動比率為1.18,速動比率為0.85。費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股價為52周低點16.06美元,52周高點為36.84美元。該公司市值為97.7億美元,市盈率為10.62倍,市盈率為0.84倍,貝塔係數為1.03。
Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA
機構投資者看好Fresenius Medical Care AG&Co.KGaA
Institutional investors and hedge funds have recently modified their holdings of the company. FDx Advisors Inc. bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $315,000. Freestone Capital Holdings LLC bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $390,000. Guardian Capital Advisors LP raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 10.7% in the 1st quarter. Guardian Capital Advisors LP now owns 52,148 shares of the company's stock valued at $1,744,000 after purchasing an additional 5,045 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 18.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 4,706 shares of the company's stock valued at $158,000 after purchasing an additional 730 shares during the period. Finally, Cacti Asset Management LLC raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 35.8% in the 1st quarter. Cacti Asset Management LLC now owns 36,000 shares of the company's stock valued at $1,212,000 after purchasing an additional 9,500 shares during the period. 5.59% of the stock is owned by institutional investors.
機構投資者和對衝基金最近調整了對該公司的持股。FDX Advisors Inc.在第一季度購買了費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的新股,價值約315,000美元。Frestone Capital Holdings LLC在第一季度購買了費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的新股,價值約39萬美元。第一季度,Guardian Capital Advisors LP將費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票持有量增加了10.7%。在此期間,Guardian Capital Advisors LP又購買了5,045股,現在擁有52,148股該公司股票,價值1,744,000美元。西北共同財富管理公司第一季度增持了費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票18.4%。西北共同財富管理公司目前持有該公司4,706股股票,價值15.8萬美元,在此期間又購買了730股。最後,Cacti Asset Management LLC在第一季度增持了費森尤斯醫療保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票35.8%。Cacti Asset Management LLC在此期間又購買了9500股,現在擁有3.6萬股該公司股票,價值121.2萬美元。5.59%的股票由機構投資者持有。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
About Fresenius Medical Care AG & Co. KGaA
關於費森尤斯醫療保健股份公司
(Get Rating)
(獲取評級)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Fresenius Medical Care AG&Co KGaA在德國、北美和國際上提供透析護理和相關的透析護理服務。它通過門診透析診所網絡提供透析治療以及相關的實驗室和診斷服務;材料、培訓和患者支持服務,包括臨牀監測、後續援助和安排將用品運送到患者住所;以及根據合同向美國醫院提供為住院的終末期腎病(ESRD)患者和急性腎功能衰竭患者提供的透析服務。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- 免費獲取StockNews.com關於Fresenius Medical Care AG&Co.KGaA(FMS)的研究報告。
- 股市:紅海中的三座強國
- 第四季度值得考慮的3家銀行
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
- MarketBeat:回顧一週9/12-9/16
- 沒有人告訴這三隻股票這是下跌的一週
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
接受Fresenius Medical Care AG&Co.KGaA Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Fresenius Medical Care AG&Co.KGaA和相關公司的最新新聞和分析師評級的每日簡要摘要。